Human Normal Immunoglobulin and Anti-D Immunoglobulin
Awarded by NHS England · 2021-01-22T15:37:11Z · £450,000,000
Description
NHS Framework Agreement for the supply of Human Normal Immunoglobulin and Anti-D Immunoglobulin. The framework will commence on 1 July 2021 for a period of 18 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points.
- Buyer
- NHS England
- Value
- £450,000,000
- Category (CPV)
- Immunoglobulins
- Award date
- 2021-01-22T15:37:11Z
- Buyer constituency
- runcorn-and-helsby
Full CPV hierarchy, related awards from the same supplier and buyer, and any declared MP interest overlaps load below when JavaScript is enabled.